PCR & NGS Based Diagnostic Testing Market Trends

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) was detected causing COVID-19. It was first originated in Wuhan, China. But soon it spread across the world and was officially declared as pandemic. The effect of COVID-19 is immensely catastrophic and pushing the healthcare system of even the developed markets such as the U.S. and Italy to the brink of collapse. Detection kits are considered as one of the key factors for tackling the spread of COVID-19 across the globe. Various research institutes and universities are adopting advanced technologies to develop advance testing kits. Medical device manufacturers have surged the development and production of COVID-19 detection kits, thus fostering the PCR & NGS based diagnostic testing market expansion.

Several companies are using their technologies and racing against time to develop PCR & NGS based diagnostic testing kits for faster detection of COVID-19 cases. GenMarkDx used its eSensor technology to minimize the risk of sample contamination. Recently, the company received Emergency Use Authorization (EUA) from FDA for its novel coronavirus diagnostic test ePlex SARS-CoV-2. XCR Diagnostics, a U.S. based startup offered their patented technology Xtreme Chain Reaction in point of care solutions. The increased importance of PCR & NGS based diagnostic testing and its high usage for virus detection during the pandemic will impel the PCR and NGS based diagnostic testing market demand.